RFG
GILD icon

RFP Financial Group’s Gilead Sciences GILD Stock Holding History

RFP Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-187
Closed -$12.9K – 376
2024
Q2 		$12.9K Sell
187
-39
-17% -$2.6K ﹤0.01% 405
2024
Q1 		$16.6K Sell
226
-57
-20% -$4.38K 0.01% 335
2023
Q4 		$23K Buy
283
+66
+30% +$5.14K 0.01% 286
2023
Q3 		$16.3K Hold
217
– – 0.01% 322
2023
Q2 		$16.7K Buy
217
+5
+2% +$399 0.01% 344
2023
Q1 		$17.6K Sell
212
-5
-2% -$414 0.02% 211
2022
Q4 		$18.6K Buy
+217
New +$17.2K 0.01% 296

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

RFP Financial Group's GILD Position: Q3 2024 in Review

RFP Financial Group sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 187 shares — an estimated $12.9K sold.

RFP Financial Group first reported a position in GILD in Q4 2022 and held it in 7 quarters. The position peaked at $23K in Q4 2023. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • RFP Financial Group reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
  • RFP Financial Group sold 187 Gilead Sciences shares in Q3 2024, an estimated $12.9K.
  • RFP Financial Group first reported a position in Gilead Sciences in Q4 2022 and held it in 7 quarters.
  • RFP Financial Group's Gilead Sciences position peaked at $23K in Q4 2023.
  • 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on RFP Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.